NASDAQ
Nautilus Biotechnology, Inc. (NAUT) has a current ratio of 13.33x as of Monday, May 25, 2026. This represents a 57.17% decrease compared to its 12-month average of 31.11x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.